Coronavirus Pandemic: Clinical trials for Sputnik V to resume and to be held in India

Oct 18, 2020, 08.35 AM(IST)
There is the good news of coronavirus vaccine trials to be conducted in India. Pharma major Dr. Reddy’s Laboratories and Russia’s sovereign wealth fund RDIF have received approval from the Drugs Controller General of India (DCGI) to conduct an adaptive phase 2/3 human clinical trial for the Sputnik V vaccine in the country.